Search

Your search keyword '"Yoh Matsuoka"' showing total 227 results

Search Constraints

Start Over You searched for: Author "Yoh Matsuoka" Remove constraint Author: "Yoh Matsuoka" Language undetermined Remove constraint Language: undetermined
227 results on '"Yoh Matsuoka"'

Search Results

2. The role of multimodal salvage therapy in the management of recurrent adrenocortical carcinoma

4. Patterns of recurrence in genuine and induced oligometastatic castration‐resistant prostate cancer treated with progressive site‐directed therapy

6. Association between immune-related adverse events and survival in patients with renal cell carcinoma treated with nivolumab plus ipilimumab: Immortal time bias-corrected analysis

7. Predictive ability of prebiopsy magnetic resonance imaging and biopsy for side‐specific negative lymph node metastasis at radical prostatectomy

9. Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study

10. Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer

11. Metastatic Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in <scp>Castration‐Resistant</scp> Prostate Cancer

18. Outcomes of gasless laparoendoscopic single‐port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique

19. Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab

20. METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer

21. A case of recurrent thrombocytopenia involving divergent immune-related mechanisms associated with pembrolizumab

22. Longitudinal changes in patient‐reported outcomes after artificial urinary sphincter implantation

23. Feasibility and outcomes of selective tetramodal bladder‐preservation therapy in elderly patients with muscle‐invasive bladder cancer

24. Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response

26. MP59-06 LONGITUDINAL CHANGE OF RENAL PARENCHYMAL VOLUME PRESERVED AFTER PARTIAL NEPHRECTOMY IN PATIENTS WITH PREEXISTING CHRONIC KIDNEY DISEASE

27. MP14-11 SIGNIFICANCE OF RADIOLOGIC INFILTRATIVE FEATURE OF PRIMARY RENAL TUMOR IN PREDICTING PATIENT SURVIVAL IN METASTATIC RENAL CELL CARCINOMA

28. Selective tetramodal bladder-preservation therapy, incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymph node dissection for muscle-invasive bladder cancer: oncological and functional outcomes of 107 patients

29. Usefulness of the inchworm sign on DWI for predicting pT1 bladder cancer progression

30. Early cancer cachexia phenotype predicts survival of advanced urothelial cancer patients treated with pembrolizumab

31. Infiltrative tumor interface with normal renal parenchyma in locally advanced renal cell carcinoma: Clinical relevance and pathological implications

32. Trends and safety of robot-assisted partial nephrectomy during the initial 2-year period after government approval in Japan: A nationwide database study from 2016 to 2018

33. Computer-aided Diagnosis with a Convolutional Neural Network Algorithm for Automated Detection of Urinary Tract Stones on Plain X-ray

34. Nonuse of antimicrobial prophylaxis in clean surgeries for adrenal and renal tumors: Results of the risk-based strategy in 1362 consecutive patients

35. Focal brachytherapy for localized prostate cancer: 5.7-year clinical outcomes and a pair-matched study with radical prostatectomy

36. Medium-term oncological and functional outcomes of hemi-gland brachytherapy using iodine-125 seeds for intermediate-risk unilateral prostate cancer

37. Genuine- and induced-oligometastatic castration-resistant prostate cancer: clinical features and clinical outcomes after progressive site-directed therapy

38. Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy: Potential of target margin and surrounding region sampling using magnetic resonance-ultrasound image fusion systems

39. Advantage of fat-derived CD73 positive cells from multiple human tissues, prospective isolated mesenchymal stromal cells

40. Impact of sarcopenia on the efficacy of pembrolizumab in patients with advanced urothelial carcinoma: a preliminary report

41. Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: A preliminary study

42. Long-term survival after radical cystectomy and mesenteric lymph node dissection for squamous cell carcinoma arising from augmented bladder with lymph node metastasis: a case report

43. Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review

44. MP34-10 THE UTILITY OF MIXED REALITY MODEL PROJECTION IN ULTRASOUND TRAINING FOR MEDICAL STUDENTS

45. MP42-13 APPARENT DIFFUSION COEFFICIENT RATIO AS A QUANTITATIVE IMAGING MARKER: UTILITY IN A NOMOGRAM FOR PREDICTING BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY

46. MP46-10 THE QSOFA SCORE OUTPERFORMS THE SIRS SCORE IN PREDICTING IN-HOSPITAL MORTALITY OF OBSTRUCTIVE PYELONEPHRITIS PATIENTS: RESULTS FROM A MULTI-INSTITUTIONAL STUDY

47. PD44-04 RELATIONSHIP BETWEEN NOCTURIA AND WHOLE-BODY FLUID DISTRIBUTION ASSESSED BY BIOELECTRICAL IMPEDANCE

48. MP40-15 LONGITUDINAL CHANGE IN URINARY INCONTINENCE, LOWER URINARY TRACT SYMPTOMS AND QUALITY OF LIFE AFTER ARTIFICIAL URINARY SPHINCTER IMPLANTATION

49. PD16-03 TREATMENT-INDUCED CHANGES OF BRAIN NATRIURETIC PEPTIDE (BNP) LEVELS IN PROSTATE CANCER PATIENTS RECEIVING GNRH ANTAGONISTS OR AGONISTS

50. MP46-15 LOW INCIDENCE OF PERIOPERATIVE INFECTIONS WITHOUT ANTIMICROBIAL PROPHYLAXIS IN CLEAN SURGERIES FOR ADRENAL AND RENAL TUMORS: A PROSPECTIVE SINGLE-INSTITUTIONAL STUDY OF 1339 PATIENTS

Catalog

Books, media, physical & digital resources